The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Oncolytics Biotech Inc down $0.02

Oncolytics Biotech Inc closed sharply lower Friday, dropping $0.02 or 3.00% to $0.49. Shares have lost 13.39% over the last five days, but have gained 83.02% over the last year to date. This security has outperformed the S&P TSX by 15.52% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated July 21 3:59 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4533
Selling / general / administrative0000
Research & development2322
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1211
Operating income-4-5-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-4-5-3-3
Income after tax-4-5-3-3
Income tax, total0000
Net income-4-5-3-3
Total adjustments to net income--------
Net income before extra. items-4-5-3-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-5-3-3
Inc. avail. to common incl. extra. items-4-5-3-3
Diluted net income-4-5-3-3
Dilution adjustment0--00
Diluted weighted average shares121121121120
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.04-0.03-0.02
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.03-0.04-0.03-0.02